gemfibrozil has been researched along with Biliary Calculi in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with uncomplicated gallstones and a serum level of low-density lipoprotein (LDL) cholesterol >130 mg/dl were randomly assigned to open-label treatment with bezafibrate, fenofibrate, gemfibrozil, or placebo for 8 weeks before elective cholecystectomy." | 5.11 | Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. ( Alegret, M; Laguna, JC; Novell, F; Roglans, N; Ros, E; Sánchez, RM; Vázquez-Carrera, M; Zambón, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roglans, N | 1 |
| Vázquez-Carrera, M | 1 |
| Alegret, M | 1 |
| Novell, F | 1 |
| Zambón, D | 1 |
| Ros, E | 1 |
| Laguna, JC | 1 |
| Sánchez, RM | 1 |
1 trial available for gemfibrozil and Biliary Calculi
| Article | Year |
|---|---|
Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.
Topics: Bezafibrate; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Cholesterol, LDL; Down-Regulatio | 2004 |